13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case

Background. Vaccination coverage in patients with rheumatic diseases remains extremely low. Moreover, infections are the leading cause of death in such patients. Respiratory infections mortality is 2–5 times higher in adults with rheumatoid arthritis than in overall population. The most frequent inf...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ekaterina I. Alekseeva, Dar’ya D. Van’kova, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy, Natalya E. Tkachenko, Maria V. Kurdup, Tatyana V. Radygina, Irina V. Zubkova
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	"Paediatrician" Publishers LLC 2019-09-01
Colección:	Вопросы современной педиатрии
Materias:	children pneumococcal disease vaccination 13-valent pneumococcal conjugate vaccine haemophilus influenzae-tetanus toxoid conjugate vaccine tocilizumab systemic juvenile idiopathic arthritis
Acceso en línea:	https://vsp.spr-journal.ru/jour/article/view/2137
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!